Effects of HMG-CoA reductase inhibitors on P2Y1 receptor-mediated IL-8 release

被引：0
|
作者：
Arai, Shouta [1 ]
Ito, Masa-aki [1 ]
Matsuoka, Isao [1 ]
机构：
[1] Takasaki Univ Hlth & Welf, Fact Pharm, Pharmacol Lab, Takasaki, Gunma 3700033, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2014年 / 124卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：199P / 199P
页数：1
相关论文
共 50 条
  • [1] Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells
    Verhulst, A
    D'haese, PC
    De Broe, ME
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (09): : 2249 - 2257
  • [2] Rac1-Mediated Effects of HMG-CoA Reductase Inhibitors (Statins) in Cardiovascular Disease
    Adam, Oliver
    Laufs, Ulrich
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (08) : 1238 - 1250
  • [3] Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
    Lee, Chong-Ki
    Choi, Jun-Shik
    Choi, Dong-Hyun
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 44 - 51
  • [4] Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
    Chong-Ki Lee
    Jun-Shik Choi
    Dong-Hyun Choi
    Pharmacological Reports, 2015, 67 : 44 - 51
  • [5] P2Y1 receptor-mediated Ca2+ propagation in the hippocampus
    Koizumi, S
    Fujishita, K
    Inoue, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 262P - 262P
  • [6] P2Y1 receptor-mediated glutamate release from cultured dorsal spinal cord astrocytes
    Zeng, Jun-Wei
    Liu, Xiao-Hong
    Zhang, Jin-Hai
    Wu, Xi-Gui
    Ruan, Huai-Zhen
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (05) : 2106 - 2118
  • [7] EFFECTS OF BEZAFIBRATE AND OF 2 HMG-COA REDUCTASE INHIBITORS ON LIPOPROTEIN-(A) LEVEL IN HYPERCHOLESTEROLEMIC PATIENTS
    BRANCHI, A
    ROVELLINI, A
    FIORENZA, AM
    SOMMARIVA, D
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995, 33 (06) : 345 - 350
  • [8] The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors
    Kusunoki, Masataka
    Sakazaki, Takahiko
    Tsutsumi, Kazuhiko
    Miyata, Tetsuro
    Oshida, Yoshiharu
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (05) : 919 - 924
  • [9] The anti-apoptotic effects of HMG-CoA reductase inhibitors on vascular endothelial cells is mediated by ASK1 suppression
    Kataoka, Keiichiro
    Kim-Mitsuyama, Shokei
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (02) : 443 - 443
  • [10] Importance of Rac1 Signaling Pathway Inhibition in the Pleiotropic Effects of HMG-CoA Reductase Inhibitors
    Rashid, Mamunur
    Tawara, Shunsuke
    Fukumoto, Yoshihiro
    Seto, Minoru
    Yano, Kazuo
    Shimokawa, Hiroaki
    CIRCULATION JOURNAL, 2009, 73 (02) : 361 - 370
12345